KMT2A / MLL Blocking Peptide

[KMT2A; KMT2A; HRX; MLL; MLL1; TRX1; ALL-1; CXXC7; HTRX1; MLL1A; WDSTS; MLL/GAS7; TET1-MLL; ALL1; CXXC7; HRX; HTRX; MLL; MLL1; TRX1; Lysine N-methyltransferase 2A; p320; p180]

[Histone-lysine N-methyltransferase 2A; Histone-lysine N-methyltransferase 2A; histone-lysine N-methyltransferase 2A; trithorax-like protein; CDK6/MLL fusion protein; MLL/GAS7 fusion protein; MLL/GMPS fusion protein; zinc finger protein HRX; mixed lineage leukemia 1; MLL-AF4 der(11) fusion protein; CXXC-type zinc finger protein 7; m; lysine (K)-specific methyltransferase 2A; ALL-1; CXXC-type zinc finger protein 7; Myeloid/lymphoid or mixed-lineage leukemia; Myeloid/lymphoid or mixed-lineage leukemia protein 1; Trithorax-like protein; Zinc finger protein HRXCleaved into the following 2 chains:MLL cleavage product N320Alternative name(s):N-terminal cleavage product of 320 kDa; p320]